Mortality in Guillain-Barre syndrome

Area of Science:

• Neurology
• Clinical Research
• Epidemiology

Background:

• Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting the peripheral nervous system.
• Understanding GBS mortality patterns is crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the frequency, timing, causes, and risk factors associated with death in Guillain-Barré syndrome.
• To identify patient subgroups at higher risk of mortality.

Main Methods:

• Analysis of prospectively collected data from 527 GBS patients across observational and therapeutic studies.
• Comparison of deceased versus surviving patients to identify risk factors for mortality.

Main Results:

• A 2.8% mortality rate was observed within 6 months, rising to 3.9% at 12 months.
• Most deaths (67%) occurred during the recovery phase, often due to respiratory or cardiovascular complications.
• Key risk factors for death included advanced age, severe weakness, mechanical ventilation, and delayed treatment.

Conclusions:

• Death in GBS disproportionately affects elderly and severely weakened patients, particularly during the recovery phase.
• Intensified monitoring may be beneficial for high-risk GBS patients to potentially reduce mortality.